Yüklüyor......
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective
When an innovative product (innovator) is not covered anymore by intellectual property rights, cheaper equivalent medicinal products (generic products) may be marketed and used in clinical practice. The regulation of generic products is well-established, and is primarily based on standard rules for...
Kaydedildi:
| Yayımlandı: | Sci Pharm |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Scientia Pharmaceutica
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4475802/ https://ncbi.nlm.nih.gov/pubmed/26171329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3797/scipharm.1312-10 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|